Financials Xiangyu Medical Co.,Ltd

Equities

688626

CNE100005394

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
38.91 ^CNY	-2.92%		-2.48%	-26.98%

Apr. 17	Xiangyu Medical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Xiangyu Medical Co.,Ltd's Equity Buyback Plan announced on August 10, 2023.	CI

Valuation

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	9,107	5,028	8,375	6,113	-	-
Enterprise Value (EV) ¹	9,107	5,028	8,375	6,113	6,113	6,113
P/E ratio	42.2 x	40.4 x	36.5 x	22.2 x	18.4 x	15.1 x
Yield	0.67%	0.75%	0.99%	1.58%	1.95%	2.17%
Capitalization / Revenue	17.4 x	10.3 x	11.2 x	6.77 x	5.53 x	4.63 x
EV / Revenue	17.4 x	10.3 x	11.2 x	6.77 x	5.53 x	4.63 x
EV / EBITDA	-	32.8 x	31.8 x	20.4 x	16.8 x	-
EV / FCF	-	-	-	-31.7 x	-72.8 x	19.9 x
FCF Yield	-	-	-	-3.16%	-1.37%	5.02%
Price to Book	4.71 x	2.65 x	4.07 x	2.72 x	2.44 x	2.22 x
Nbr of stocks (in thousands)	160,000	157,726	157,153	157,109	-	-
Reference price ²	56.92	31.88	53.29	38.91	38.91	38.91
Announcement Date	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	523.5	488.5	744.8	903	1,106	1,320
EBITDA ¹	-	-	153.2	263.5	299	363	-
EBIT ¹	-	224.1	135.5	247.4	306	371	451
Operating Margin	-	42.8%	27.73%	33.22%	33.89%	33.53%	34.18%
Earnings before Tax (EBT) ¹	-	222.7	133	246.8	305.5	370	450
Net income ¹	196.3	201.9	125.5	229.6	280.2	337.9	412.5
Net margin	-	38.57%	25.68%	30.82%	31.03%	30.55%	31.26%
EPS ²	1.640	1.350	0.7900	1.460	1.750	2.110	2.575
Free Cash Flow ¹	-	-	-	-	-193	-84	307
FCF margin	-	-	-	-	-21.37%	-7.59%	23.27%
FCF Conversion (EBITDA)	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	74.42%
Dividend per Share ²	-	0.3800	0.2400	0.5300	0.6150	0.7600	0.8450
Announcement Date	4/28/21	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2024 Q1
Net sales ¹	169.1
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	39.07
Net margin	23.11%
EPS	-
Dividend per Share	-
Announcement Date	4/17/24

¹CNY in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	-	-193	-84	307
ROE (net income / shareholders' equity)	-	12.6%	6.53%	11.4%	12.2%	13.1%	15%
ROA (Net income/ Total Assets)	-	12.7%	5.51%	9.23%	9.9%	10.3%	11.4%
Assets ¹	-	1,586	2,275	2,488	2,830	3,273	3,618
Book Value Per Share ²	-	12.10	12.00	13.10	14.30	15.90	17.60
Cash Flow per Share ²	-	1.040	1.170	1.420	1.860	2.270	2.800
Capex ¹	-	134	203	479	321	263	170
Capex / Sales	-	25.57%	41.55%	64.33%	35.51%	23.8%	12.88%
Announcement Date	4/28/21	2/22/22	2/10/23	2/21/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Xiangyu Medical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

38.91 CNY

Average target price

50.78 CNY

Spread / Average Target

+30.51%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
XIANGYU MEDICAL CO.,LTD	-26.98%	846M
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	-0.04%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology